Table 1.
Gene | Age at onset | Phenotype at onset | Additional features | Neuroimaging | |
---|---|---|---|---|---|
MAPT | 46.3 | PSP-P and PSP-F | Family history Visual grasping |
MRI PET |
Mild and diffuse brain atrophy (PSP-P/RS) Symmetrical atrophy of anterior temporal lobe greater than frontal lobe, with spared cerebellum (PSP-F) Frontal reduced metabolism |
C9orf72 | 64 | PSP-RS and PSP-F | Family history Hallucinations MND |
MRI PET |
Symmetrical atrophy of frontal predominant with cerebellar involvement. Bilateral frontal and temporal hypometabolism |
ATP13A2 | 14.9 | PSP-P and PSP-RS | Facial-faucial-finger mini-myoclonus | MRI PET DAT |
Diffuse cerebellar atrophy with cerebellar involvement Bilateral striatal hypometabolism Nigrostriatal dopaminergic dysfunction. |
NPC1/2 | ≥15 | PSP-F and PSP-OM | Refractory schizophrenia-like Ataxia Segmental dystonia Leg spasticity |
MRI | Frontal and corpus callosum atrophy (PSP-F) Brainstem and cerebellar atrophy (PSP-OM) |
GRN | 60 | PSP-F and PSP-SL | Family history Visual hallucinations Episodic memory impairment |
MRI | Asymmetrical frontotemporal and parietal atrophy. |
SYNJ1 | 24.7 | PSP-P | Developmental delay Levodopa induced dyskinesias |
MRI PET DAT |
Normal or cortical and midbrain atrophy Cortical and caudate hypometabolism Nigrostriatal dopaminergic dysfunction. |
DCTN1 | 59.5 | PSP-P and PSP-F | Family history | MRI SPECT |
Mild diffuse or frontoparietal atrophy with brainstem involvement Frontal hypoperfusion |
PRNP | 52.9 | PSP-P and PSP-F | Cerebellar ataxia Nystagmus |
MRI | Normal, cortical ribbon, iron deposition in the basal ganglia and/or cerebellar atrophy. |
PET: FDG-PET; DAT: DAT-SPECT.